Gain-of-Function Mutant TP53 R248Q Overexpressed in Epithelial Ovarian Carcinoma Alters AKT-Dependent Regulation of Intercellular Trafficking in Responses to EGFR/MDM2 Inhibitor.

MLA

Lai, Zih-Yin, et al. “Gain-of-Function Mutant TP53 R248Q Overexpressed in Epithelial Ovarian Carcinoma Alters AKT-Dependent Regulation of Intercellular Trafficking in Responses to EGFR/MDM2 Inhibitor.” International Journal of Molecular Sciences, vol. 22, no. 16, Aug. 2021, p. 8784. EBSCOhost, https://doi.org/10.3390/ijms22168784.

APA

Lai, Z.-Y., Tsai, K.-Y., Chang, S.-J., & Chuang, Y.-J. (2021). Gain-of-Function Mutant TP53 R248Q Overexpressed in Epithelial Ovarian Carcinoma Alters AKT-Dependent Regulation of Intercellular Trafficking in Responses to EGFR/MDM2 Inhibitor. International Journal of Molecular Sciences, 22(16), 8784. https://doi.org/10.3390/ijms22168784

Chicago

Lai, Zih-Yin, Kai-Yun Tsai, Shing-Jyh Chang, and Yung-Jen Chuang. 2021. “Gain-of-Function Mutant TP53 R248Q Overexpressed in Epithelial Ovarian Carcinoma Alters AKT-Dependent Regulation of Intercellular Trafficking in Responses to EGFR/MDM2 Inhibitor.” International Journal of Molecular Sciences 22 (16): 8784. doi:10.3390/ijms22168784.